BPG is committed to discovery and dissemination of knowledge
Articles in Press
10/29/2024 11:10:47 AM | Browse: 52 | Download: 1
Publication Name World Journal of Hepatology
Manuscript ID 100509
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus
Manuscript Source Unsolicited Manuscript
All Author List Hua-Dong Li, Ya-Nan Liu, Shuang Wu, Xu-Feng Quan, Xiao-Yan Wang, Tian-Dan Xiang, Shu-Meng Li, Ling Xu, Tong Wang, Hua Wang and Xin Zheng
Funding Agency and Grant Number
Funding Agency Grant Number
Wuhan Science and Technology Bureau Knowledge Innovation Special Foundation of Hubei Province 2022020801010588
National Key R and D Projects 2022YFC2305100
National Science and Technology Major Project of China 92169121
Corresponding Author Xin Zheng, MD, PhD, Professor, Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, Hubei Province, China. xinz@hust.edu.cn
Key Words Nonalcoholic fatty liver disease; Chronic hepatitis B; Nucleoside analogues; Antiviral therapy; Virological response
Core Tip The effect of nonalcoholic fatty liver disease (NAFLD) on the antiviral therapy with nucleoside analogues (NAs) in patients with chronic hepatitis B (CHB) is controversial. The aim of this study was to investigate the virological response to first-line NAs antiviral treatment in patients with NAFLD and CHB, through dynamically monitoring virology indicators for 96 weeks, to determine the influence of NAFLD on the efficacy of NAs anti- hepatitis B virus treatment. To our knowledge, this is the first grading study based on HBV baseline viral load that confirms a reduction in virological response to NAs antiviral treatment caused by NAFLD.
Citation <p>Li HD, Liu YN, Wu S, Quan XF, Wang XY, Xiang TD, Li SM, Xu L, Wang T, Wang H, Zheng X. Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus. <i>World J Hepatol</i> 2024; 16(12): 1395-1406</p>
Received
2024-08-18 14:18
Peer-Review Started
2024-08-18 14:18
To Make the First Decision
Return for Revision
2024-09-18 03:14
Revised
2024-10-02 01:04
Second Decision
2024-10-29 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-10-29 11:10
Articles in Press
2024-10-29 11:10
Publication Fee Transferred
2024-10-31 16:01
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-11-22 01:41
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com